Abstract
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that regulate lipid and glucose metabolism and cellular differentiation. PPAR-α and PPAR-γ are both expressed in human macrophages where they exert anti-inflammatory effects. The activation of PPAR-α may promote foam-cell formation by inducing expression of the macrophage scavenger receptor CD36. This prompted us to investigate the influence of different PPAR- activators on cholesterol metabolism and foam-cell formation of human primary and THP-1 macrophages. Here we show that PPAR-α and PPAR-γ activators do not influence acetylated low density lipoprotein-induced foam-cell formation of human macrophages. In contrast, PPAR-α and PPAR-γ activators induce the expression of the gene encoding ABCA1, a transporter that controls apoAI-mediated cholesterol efflux from macrophages. These effects are likely due to enhanced expression of liver-x-receptor α, an oxysterol-activated nuclear receptor which induces ABCA1- promoter transcription. Moreover, PPAR-α and PPAR-γ activators increase apoAI-induced cholesterol efflux from normal macrophages. In contrast, PPAR-α or PPAR-γ activation does not influence cholesterol efflux from macrophages isolated from patients with Tangier disease, which is due to a genetic defect in ABCA1. Here we identify a regulatory role for PPAR-α and PPAR-γ in the first steps of the reverse-cholesterol-transport pathway through the activation of ABCA1-mediated cholesterol efflux in human macrophages.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pineda Torra, I., Gervois, P. & Staels, B. Peroxisome proliferator-activated receptor α in metabolic disease, inflammation, atherosclerosis and aging. Curr. Opin. Lipidol. 10, 151–159 (1999).
Brun, R.P. et al. Differential activation of adipogenesis by multiple PPAR- isoforms. Genes Dev. 10, 974–984 (1996).
Jiang, C., Ting, A.T. & Seed, B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82–86 (1998).
Ricote, M., Li, A.C., Willsson, T.M., Kelly, C.J. & Glass, C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79–82 (1998).
Chinetti, G. et al. Activation of peroxisome proliferator-activated receptorsγ and γ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273, 25573–25580 (1998).
Tontonoz, P., Nagy, L., Alvarez, J., Thomazy, V. & Evans, R. PPAR-γ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241–252 (1998).
Chinetti, G. et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101, 2411–2417 (2000).
Brooks-Wilson, A. et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nature Genet. 22, 336–345 (1999).
Lawn, R.M. et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104, R25–R31 (1999).
Bodzioch, M. et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nature Genet. 22, 347–351 (1999).
Rust, S. et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nature Genet. 22, 352–355 (1999).
Hobbs, H.H. & Rader, D.J. ABC1: connecting yellow tonsils, neuropathy, and very low HDL. J. Clin. Invest. 104, 1015–1007 (1999).
Wolffenbuttel, B.H., Gomis, R., Squatrito, S., Jones, N.P. & Patwardhan, R.M. Addition of low-dose rosiglitazone to sulphonylurea therapy glycaemic control in Type 2 diabetic patients. Diabet. Med. 17, 40–47 (2000).
Vu-Dac, N. et al. The nuclear receptor peroxisome proliferator-activated Receptors α and Rev-erb γ mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J. Biol. Chem. 273, 25713–25720 (1998).
Janowski, B.A., Willy, P.J., Devi, T.R., Falck, J.R. & Mangelsdorf, D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR-α. Nature 383, 728–731 (1996).
Costet, P., Luo, Y., Wang, N. & Tall, A.R. Sterol-dependent transactivation of the human ABC1 promoter by LXR-/RXR. J. Biol. Chem. 275, 28240–28245 (2000).
Frick, M.H. et al. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation 96, 2137–2143 (1997).
Ericsson, C. et al. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 347, 849–53 (1996).
Law, R. et al. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98, 1897–1905 (1996).
Rubins, H.B. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N. Engl. J. Med. 341, 410–418 (1999).
Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801–809 (1993).
Willson, T.M., Brown, P.J., Sternbach, D.D. & Henke, B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43, 527–550 (2000).
Forman, B.M., Ruan, B., Chen, J., Schroepfer, G.J. Jr. & Evans, R.M. The orphan nuclear receptor LXR-α is positively and negatively regulated by distinct products of mevalonate metabolism. Proc. Natl. Acad. Sci. USA 94, 10588–10593 (1997).
Venkateswaran, A. et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR-α. Proc. Natl. Acad. Sci. USA 97, 12097–12102 (2000).
Forte, T.M. & McCall, M.R. The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis. Curr. Opin. Lipidol. 5, 354–364 (1994).
Becq, F. et al. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes. J. Biol. Chem. 272, 2695–2699 (1997).
Hamon, Y. et al. Interleukin-1β secretion is impaired by inhibitors of the ATP binding cassette transporter, ABC1. Blood 90, 2911–2915 (1997).
Remaley, A.T. et al. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc. Natl. Acad. Sci. USA 96, 12685–12690 (1999).
Marx, N., Sukhova, G., Murphy, C., Libby, P. & Plutzky, J. Macrophages in human atheroma contain PPAR-γ: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPAR-γ) expression and reduction of MMP-9 activity through PPAR-gamma activation in mononuclear phagocytes in vitro. Am. J. Pathol. 153, 17–23 (1998).
Tobin, K.A. et al. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-α. Mol. Endocrinol. 14, 741–752 (2000).
Ji, Y. et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272, 20982–20985 (1997).
Barman Balfour, J.A. & Plosker, G.L. Rosiglitazone. Drugs 57, 921–930 (1999).
Staels, B. et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088–2093 (1998).
Vu-Dac, N. et al. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96, 741–750 (1995).
Delerive, P. et al. Oxidized phospholipids activate PPAR-α in a phospholipase A2-dependant manner. FEBS Lett. 471, 34–38 (2000).
Basu, S.K., Goldstein, J.L., Anderson, G.W. & Brown, M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA 73, 3178–3182 (1976).
Kritharides, L., Christian, A., Stoudt, G., Morel, D. & Rothblat, G.H. Cholesterol metabolism and efflux in human THP-1 macrophages. Arterioscler. Throm. Vasc. Biol. 18, 1589–1599 (1998).
Folch, J., Lees, M. & Sloane Stanley, G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497–5 (1957).
Acknowledgements
We thank the Etablissement Français du sang- Nord de France for buffy coats of healthy individuals; A. Shevelev for the pcDNA3-hLXR-α plasmid; A. Bril for rosiglitazone; and B. Derudas, P. Poulain, N. Tian and G. Searfoss for technical contribution. This work was supported by grants from the Fondation pour la Recherche Médicale (to G.C.), Aventis Pharma and ARCOL.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chinetti, G., Lestavel, S., Bocher, V. et al. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7, 53–58 (2001). https://doi.org/10.1038/83348
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/83348
This article is cited by
-
Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
Cell Death & Disease (2023)
-
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Nature Reviews Neuroscience (2023)
-
Reexamining the Causes and Effects of Cholesterol Deposition in the Brains of Patients with Alzheimer’s Disease
Molecular Neurobiology (2023)
-
Drug repurposing by in silico prediction of cyclizine derivatives as antihyperlipemic agents
In Silico Pharmacology (2023)
-
Chronic inflammatory effects of in vivo irradiation of the murine heart on endothelial cells mimic mechanisms involved in atherosclerosis
Strahlentherapie und Onkologie (2023)